Get the app
US › Healthcare

The Joint Corp (JYNT)

US · Healthcare · Medical Care Facilities

$8.43-2.32%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$15.2M
Revenue YoY
+14.4%
Net profit
$653,021
Profit YoY
+599.4%
EPS
$-0.01
EPS estimate
$0.11
Net margin
4.3%

EPS came in at -0.01 against a street estimate of 0.11 — a miss of 109.1%.

Key statistics

Market cap
$113.6M
P/E
57.4
Forward P/E
11.5
P/B
7.19
Book value
$1.16
EPS (TTM)
$0.14
52-week high
$10.67
52-week low
$7.50
50-day MA
$8.56
200-day MA
$8.82
Beta
1.06

Analyst view

Analysts rate The Joint Corp a buy (3 buy, 2 hold, 0 sell out of 5) with an average price target of $10.00.

Shareholding

Insiders
16.23%
Institutions
69.27%

Largest institutional holders

FundStake
Bandera Partners LLC27.84%
Skylands Capital, LLC6.33%
BlackRock Inc5.33%
Vanguard Capital Management, LLC4.21%
JCP Investment Management, LLC4.20%
Keller Group Invmt Management Inc2.39%
Geode Capital Management, LLC2.03%
State Street Corp2.02%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for The Joint Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.